These results are in agreement with a recent study that found DAGLA polymorphisms associated with neurodevelopmental disorders and seizures (Smith et al., 2017), while CB1 receptor associated with pain sensitivity, sleep, memory or anxiety, but not seizures. The gene discussed is DAGLA; the disease is neurodevelopmental disorder.